• 1785 Citations
  • 24 h-Index
20002018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jade Homsi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Methylphenidate Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Hydrocodone Medicine & Life Sciences
Dacarbazine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2018

  • 1785 Citations
  • 24 h-Index
  • 38 Article
  • 10 Review article
1 Citation (Scopus)

A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma

McQuade, J. L., Homsi, J., Torres-Cabala, C. A., Bassett, R., Popuri, R. M., James, M. L., Vence, L. M. & Hwu, W. J., Dec 19 2018, In : BMC Cancer. 18, 1, 1274.

Research output: Contribution to journalArticle

Immunologic Adjuvants
Interleukin-2
Melanoma
Neoplasms
Proteins
118 Citations (Scopus)

PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma

Migden, M. R., Rischin, D., Schmults, C. D., Guminski, A., Hauschild, A., Lewis, K. D., Chung, C. H., Hernandez-Aya, L., Lim, A. M., Chang, A. L. S., Rabinowits, G., Thai, A. A., Dunn, L. A., Hughes, B. G. M., Khushalani, N. I., Modi, B., Schadendorf, D., Gao, B., Seebach, F., Li, S. & 17 others, Li, J., Mathias, M., Booth, J., Mohan, K., Stankevich, E., Babiker, H. M., Brana, I., Gil-Martin, M., Homsi, J., Johnson, M. L., Moreno, V., Niu, J., Owonikoko, T. K., Papadopoulos, K. P., Yancopoulos, G. D., Lowy, I. & Fury, M. G., Jul 26 2018, In : New England Journal of Medicine. 379, 4, p. 341-351 11 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Skin
Confidence Intervals
Constipation
Therapeutics
1 Citation (Scopus)

Phase I/II study of hepatic arterial infusion of nab-paclitaxel in patients with metastatic melanoma to the liver

Vera-Aguilera, J., Bedikian, A. Y., Bassett, R. L., Hwu, W. J., Kim, K. B., Qin, Y., Cain, S., Washington, E. W., Davies, M. A., Patel, S. M., Homsi, J., Papadopoulos, N. E., Hwu, P. & Patel, S. P., Nov 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 11, p. 1132-1136 5 p.

Research output: Contribution to journalArticle

Nanoparticles
Melanoma
Liver
Neoplasm Metastasis
Maximum Tolerated Dose
8 Citations (Scopus)

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma

Patel, S. P., Kim, D. W., Bassett, R. L., Cain, S., Washington, E., Hwu, W. J., Kim, K. B., Papadopoulos, N. E., Homsi, J., Hwu, P. & Bedikian, A. Y., Oct 1 2017, In : Cancer Immunology, Immunotherapy. 66, 10, p. 1359-1366 8 p.

Research output: Contribution to journalArticle

temozolomide
Melanoma
Dacarbazine
Regulatory T-Lymphocytes
Constipation
2 Citations (Scopus)

The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis

Puri, A. & Homsi, J., Jan 1 2017, In : Melanoma Research. 27, 5, p. 519-523 5 p.

Research output: Contribution to journalArticle

Melanoma
Rheumatoid Arthritis
Safety
Immunotherapy
Autoimmune Diseases